ทวิตเตอร์ | ค้นหา | |
Karyopharm
Karyopharm Therapeutics Inc. is a clinical-stage pharma company focused on discovery and development of novel drugs to treat cancer and other major diseases.
24
ทวีต
195
กําลังติดตาม
95
ผู้ติดตาม
ทวีต
Karyopharm 9 ม.ค.
At ? Come see Christopher Primiano, JD, MBA, SVP of Operations & Business Development and General Counsel & Secretary at present tomorrow Jan. 10 at 7:30 AM PST (10:30 AM ET). The presentation will be accessible via live webcast available here
Reply Retweet ชื่นชอบ
Karyopharm 3 ม.ค.
to Present at the 36th Annual J.P. Morgan Healthcare Conference Wednesday, Jan. 10, at 7:30 AM PST (10:30 AM ET).
Reply Retweet ชื่นชอบ
Karyopharm 10 ธ.ค.
Presents Positive Phase 1/2 Eltanexor Data at
Reply Retweet ชื่นชอบ
Karyopharm 10 ธ.ค.
Presents Positive Selinexor Data from the Phase 1b/2 STOMP Study at
Reply Retweet ชื่นชอบ
Karyopharm 10 ธ.ค.
is presenting today @ Abstract #3134, a clinical study of Eltanexor (KPT-8602), a 2nd Generation SINE Compound, in PTs w/ Multiple Myeloma @ Bldg A, Lvl 1, Hall A2 today, 6-8 PM
Reply Retweet ชื่นชอบ
Karyopharm 10 ธ.ค.
is presenting @ Abstract #3100, a Phase 1b STOMP Study that Assesses the Combo of Selinexor & Daratumumab in PTs w/ Previously Exposed to PIs & IMiDs @ Bldg A, Lvl 1, Hall A2 today, 6-8 PM
Reply Retweet ชื่นชอบ
Karyopharm 10 ธ.ค.
is presenting @ Abstract #1816, a study of Selinexor Combo with Lenalidomide and Low Dose Dex in PTs w/ from their Phase 1b/2 STOMP Trial @ Bldg A, Lvl 1, Hall A2 today, 5:30-7:30 PM
Reply Retweet ชื่นชอบ
Karyopharm 10 ธ.ค.
is presenting @ Abstract #3135, which features data from its Phase 1b/2 STOMP Study highlighting Selinexor in Combo w/ Weekly Low Dose Bortezomib and Dex for @ Bldg A, Lvl 1, Hall A2 today, 6-8 PM
Reply Retweet ชื่นชอบ
Karyopharm 9 ธ.ค.
is presenting @ Abstract #1861, data from an arm of the Phase 1b/2 STOMP trial evaluating selinexor in combo with Revlimid and low dose dex in patients w/ @ Bldg A, Lvl 1, Hall A2 today, 5:30-7:30 PM ET
Reply Retweet ชื่นชอบ
Karyopharm 22 พ.ย.
Thank you to all who joined employees this week in donating their hair at the in Newton, MA. All donations will go to and .
Reply Retweet ชื่นชอบ
Karyopharm 2 พ.ย.
to Present Phase 1b/2 STOMP Clinical Data at the American Society of Hematology 2017 Annual Meeting
Reply Retweet ชื่นชอบ
Karyopharm 2 พ.ย.
การตอบกลับถึง @Karyopharm
Reply Retweet ชื่นชอบ
Karyopharm 2 พ.ย.
Karyopharm Reports Third Quarter 2017 Financial Results and Highlights Recent Progress
Reply Retweet ชื่นชอบ
Karyopharm 1 พ.ย.
to Present Phase 1b/2 STOMP Clinical Data at the American Society of Hematology 2017 Annual Meeting
Reply Retweet ชื่นชอบ
Karyopharm 12 ต.ค.
& Sign Excl License Agmt to Dev & Commercialize Selinexor & KPT-8602 in JPN & Other Countries in Asia
Reply Retweet ชื่นชอบ
Karyopharm 12 ต.ค.
& Sign Excl License Agmt to Dev & Commercialize Selinexor & KPT-8602 in JPN & Other Countries in Asia.
Reply Retweet ชื่นชอบ
Karyopharm 20 ก.ย.
Karyopharm Announces Successful Outcome from Phase 2 Portion of Phase 2/3 SEAL Study Evaluating Selinexor
Reply Retweet ชื่นชอบ
Karyopharm 12 ก.ย.
Appoints Michael Falvey as CFO, Adds Clinical Strategy & Human Resources Executives & Reports Inducement Grant
Reply Retweet ชื่นชอบ
Karyopharm 8 ก.ย.
Announces Presentation of Selinexor and KPT-9274 Clinical Data at … see full story here:
Reply Retweet ชื่นชอบ
Karyopharm 30 ส.ค.
Newton Community, join Karyopharm & donate for Hurricane Harvey–item drop off in the 1st floor lobby at 85 Wells Ave
Reply Retweet ชื่นชอบ